International Biotechnology Trust Plc Buys ChemoCentryx Inc, Turning Point Therapeutics Inc, Mirati Therapeutics Inc, Sells Neurocrine Biosciences Inc, MyoKardia Inc, Immunomedics Inc

• New Purchases: ORIC, AXSM, TVTX,
• Added Positions: CCXI, TPTX, MRTX, VRTX, AMGN, BHVN, HZNP, ALXN, IONS, PTCT, DCPH, ITCI, GILD,
• Reduced Positions: NBIX, BIIB, IOVA, AUPH,
• Sold Out: MYOK, IMMU, IMUX, ARNA, CYTK,

For the details of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's stock buys and sells, go to https://www.gurufocus.com/guru/international+biotechnology+trust+plc/current-portfolio/portfolio

1. Horizon Therapeutics PLC (HZNP) - 444,000 shares, 8.91% of the total portfolio. Shares added by 14.14%
2. ACADIA Pharmaceuticals Inc (ACAD) - 486,000 shares, 7.13% of the total portfolio.
3. Vertex Pharmaceuticals Inc (VRTX) - 97,322 shares, 6.30% of the total portfolio. Shares added by 50.14%
4. Biomarin Pharmaceutical Inc (BMRN) - 247,584 shares, 5.95% of the total portfolio.
5. PTC Therapeutics Inc (PTCT) - 333,000 shares, 5.58% of the total portfolio. Shares added by 11.37%

International Biotechnology Trust Plc initiated holding in ORIC Pharmaceuticals Inc. The purchase prices were between $20.32 and $39.8, with an estimated average price of $28.77. The stock is now traded at around $34.110000. The impact to a portfolio due to this purchase was 0.49%. The holding were 53,000 shares as of 2020-12-31.

International Biotechnology Trust Plc initiated holding in Axsome Therapeutics Inc. The purchase prices were between $66.31 and $86.52, with an estimated average price of $74.82. The stock is now traded at around $72.270000. The impact to a portfolio due to this purchase was 0.31%. The holding were 14,000 shares as of 2020-12-31.

International Biotechnology Trust Plc initiated holding in Travere Therapeutics Inc. The purchase prices were between $19.17 and $27.87, with an estimated average price of $23.41. The stock is now traded at around $30.650000. The impact to a portfolio due to this purchase was 0.15%. The holding were 20,000 shares as of 2020-12-31.

International Biotechnology Trust Plc added to a holding in ChemoCentryx Inc by 983.05%. The purchase prices were between $47.25 and $65.16, with an estimated average price of $57.29. The stock is now traded at around $67.620000. The impact to a portfolio due to this purchase was 3.93%. The holding were 255,600 shares as of 2020-12-31.

International Biotechnology Trust Plc added to a holding in Turning Point Therapeutics Inc by 224.40%. The purchase prices were between $88.19 and $130.94, with an estimated average price of $109.9. The stock is now traded at around $121.930000. The impact to a portfolio due to this purchase was 2.62%. The holding were 113,541 shares as of 2020-12-31.

International Biotechnology Trust Plc added to a holding in Mirati Therapeutics Inc by 150.56%. The purchase prices were between $162.05 and $240.27, with an estimated average price of $216.92. The stock is now traded at around $204.710000. The impact to a portfolio due to this purchase was 2.44%. The holding were 67,400 shares as of 2020-12-31.

International Biotechnology Trust Plc added to a holding in Vertex Pharmaceuticals Inc by 50.14%. The purchase prices were between $207.01 and $276.09, with an estimated average price of $228.74. The stock is now traded at around $207.020000. The impact to a portfolio due to this purchase was 2.1%. The holding were 97,322 shares as of 2020-12-31.

International Biotechnology Trust Plc added to a holding in Amgen Inc by 63.64%. The purchase prices were between $216.38 and $257.67, with an estimated average price of $230.16. The stock is now traded at around $231.690000. The impact to a portfolio due to this purchase was 1.77%. The holding were 72,000 shares as of 2020-12-31.

International Biotechnology Trust Plc added to a holding in Biohaven Pharmaceutical Holding Co Ltd by 45.85%. The purchase prices were between $65.07 and $98.24, with an estimated average price of $85.04. The stock is now traded at around $82.890000. The impact to a portfolio due to this purchase was 1.48%. The holding were 200,400 shares as of 2020-12-31.

International Biotechnology Trust Plc sold out a holding in MyoKardia Inc. The sale prices were between $139.6 and $224.91, with an estimated average price of $220.55.

International Biotechnology Trust Plc sold out a holding in Immunomedics Inc. The sale prices were between $85.08 and $87.86, with an estimated average price of $86.65.

International Biotechnology Trust Plc sold out a holding in Immunic Inc. The sale prices were between $14.8 and $20.37, with an estimated average price of $17.94.

International Biotechnology Trust Plc sold out a holding in Arena Pharmaceuticals Inc. The sale prices were between $63.85 and $87.71, with an estimated average price of $74.94.

International Biotechnology Trust Plc sold out a holding in Cytokinetics Inc. The sale prices were between $15.26 and $28.61, with an estimated average price of $18.21.